Budget impact models for lung cancer interventions: A systematic literature review

  • 0The Swedish Institute for Health Economics, Lund, Sweden.

|

|

Summary

This summary is machine-generated.

Budget impact models (BIMs) for lung cancer show variability and room for improvement in forecasting financial implications. Adherence to best practices was inconsistent, highlighting a need for enhanced model quality in healthcare decision-making.

Area Of Science

  • Health economics
  • Pharmacoeconomics
  • Oncology

Background

  • Budget impact models (BIMs) are crucial for assessing new healthcare technology adoption and budget reallocation.
  • Discrepancies exist between BIM estimates and actual financial outcomes.
  • An AI-driven tool is being developed to identify non-small cell lung cancer patients benefiting from immunotherapy.

Purpose Of The Study

  • To evaluate the budgetary implications of lung cancer interventions.
  • To conduct a systematic literature review of published BIMs for lung cancer.

Main Methods

  • Systematic literature search of PubMed and EMBASE (2010-2023) for lung cancer BIMs.
  • Extraction of model characteristics, including interventions, costs, and adherence to best practices.
  • Evaluation against Professional Society for Health Economics and Pharmacoeconomics Research guidelines.

Main Results

  • 25 BIMs were identified across 14 countries, with variable model structure clarity.
  • Cost calculator approach was common; time horizons were generally appropriate.
  • Market uptake assumptions were poorly documented, and cancer-related costs were rarely included.
  • Adherence to best practices was inconsistent and did not improve over time.

Conclusions

  • The number of lung cancer BIMs published is substantial, with modest improvements in frequency and quality.
  • Significant variability and suboptimal adherence to best practices were observed.
  • While no single model was ideal for evaluating AI tools, insights were gained for future development.

Related Concept Videos

Cancer Survival Analysis 01:21

334

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Cancer Therapies 02:49

7.6K

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Statistical Methods for Analyzing Epidemiological Data 01:25

330

Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:

Descriptive Statistics: These provide basic...